IPOs: Singulex, Radius Health
IPO Desktop President Francis Gaskins believes investors should wait until these biotech offerings prove they are healthy.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
